Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Feb 15;19(814):340-345.
doi: 10.53738/REVMED.2023.19.814.340.

[Practice review on the use of proton pump inhibitors]

[Article in French]
Naïm Razgallah  1 , Domenico Galasso  2 , Ferdinand Le Bloc'h  3 , Mathieu Firmann  1
Affiliations
Review

[Practice review on the use of proton pump inhibitors]

[Article in French]
Naïm Razgallah et al. Rev Med Suisse. .

Abstract
in English, French

Proton pump inhibitors (PPI), these antacid drugs that have revolutionized the treatment of peptic disease, have become, in the daily practice of primary care physicians as well as hospital practitioners, an inescapable treatment since their introduction on the market in 1989, and even the 4th most prescribed drug class in Switzerland. Therefore, multiple studies as well as numerous recommendations and expert opinions on their effectiveness and use have been -published. This article will present their proper use, by reviewing the knowledge available to date on these essential drugs in our -therapeutic arsenal.

Les inhibiteurs de la pompe à protons (IPP), ces médicaments antiacides ayant révolutionné le traitement de la maladie peptique, sont devenus, dans la pratique quotidienne du médecin de premier recours tout comme du praticien hospitalier, un traitement incontournable depuis leur mise sur le marché en 1989, et sont même la 4e classe médicamenteuse la plus prescrite en Suisse. Par conséquent, de multiples études ainsi que de nombreux ­avis d’experts et recommandations sur leur efficacité et leur ­utilisation ont été publiés. L’objectif de cet article est de ­présenter leur bon usage et de passer en revue les connaissances actuel­lement disponibles sur ces médicaments essentiels de notre ­arsenal thérapeutique.

PubMed Disclaimer

Conflict of interest statement

Les auteurs n’ont déclaré aucun conflit d’intérêts en relation avec cet article.

Substances

LinkOut - more resources